We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Here we applied this approach to develop a bivalentvaccine against pneumococcus and S. typhi.
2
Cross-reactive seropositivity is more common in women with high anti-HPV16 antibody response and in the bivalentvaccine recipients.
3
We developed in this study a bivalentvaccine against the two viruses through a recently developed polyvalent complex platform.
4
Vaccination with the bivalentvaccine at day 1 resulted in a decreased spleen colonization by both Salmonella Infantis and Enteritidis.
5
We conducted a cost-utility analysis of screening and immunization with the bivalentvaccine for the Canadian setting from the Ministry of Health perspective.
6
In particular, the bivalentvaccine provides additional protection against HPV 31, 33, and 45 and the quadrivalent vaccine against HPV31.
7
Here, we expand our investigation of the immunogenic properties of these bivalentvaccines in mice.